DNMT3A and inflammatory bowel disease: Interestingly, a genome-wide association study has shown that noncoding polymorphisms in the de novo methyltransferase enzyme DNMT3A locus are associated with a higher risk for IBD, and for Crohn ́s disease (CD) in particular11.